Literature DB >> 7581481

The CYP2A gene subfamily: species differences, regulation, catalytic activities and role in chemical carcinogenesis.

P Fernandez-Salguero1, F J Gonzalez.   

Abstract

The CYP2A subfamily has been characterized in several mammalian species including mouse, rat, rabbit, hamster, cattle and human. Marked species differences have been demonstrated in the catalytic activities and regulation of this subfamily. In humans, the CYP2A genes are found as a cluster on the long arm of chromosome 19 with the CYP2B and CYP2F genes. Marked interindividual differences in expression of the CYP2A6 gene was found in livers analyzed in vitro and in humans phenotyped in vivo by using coumarin, a specific substrate for the enzyme. Efforts are underway to determine the existence of mutant and variant CYP2A6 alleles in the human population. Since CYP2A6 is able to metabolically-activate chemical carcinogens and is expressed in extrahepatic tissue, it will be of interest to determine whether genetic differences in expression of the gene is associated with cancer risk.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7581481     DOI: 10.1097/00008571-199512001-00013

Source DB:  PubMed          Journal:  Pharmacogenetics        ISSN: 0960-314X


  10 in total

Review 1.  Genetic polymorphism of drug metabolizing enzymes: new mutations in CYP2D6 and CYP2A6 genes in Japanese.

Authors:  T Yokoi; T Kamataki
Journal:  Pharm Res       Date:  1998-04       Impact factor: 4.200

2.  Involvement of multiple human cytochromes P450 in the liver microsomal metabolism of astemizole and a comparison with terfenadine.

Authors:  S Matsumoto; Y Yamazoe
Journal:  Br J Clin Pharmacol       Date:  2001-02       Impact factor: 4.335

3.  Comparison of CYP2A6 catalytic activity on coumarin 7-hydroxylation in human and monkey liver microsomes.

Authors:  Y Li; N Y Li; E M Sellers
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1997 Oct-Dec       Impact factor: 2.441

Review 4.  The emerging role of microRNAs in drug responses.

Authors:  Wei Zhang; M Eileen Dolan
Journal:  Curr Opin Mol Ther       Date:  2010-12

5.  Cell-specific expression of CYP2A5 in the mouse respiratory tract: effects of olfactory toxicants.

Authors:  Elena Piras; Anna Franzén; Estíbaliz L Fernández; Ulrika Bergström; Françoise Raffalli-Mathieu; Matti Lang; Eva B Brittebo
Journal:  J Histochem Cytochem       Date:  2003-11       Impact factor: 2.479

6.  SXR, a novel steroid and xenobiotic-sensing nuclear receptor.

Authors:  B Blumberg; W Sabbagh; H Juguilon; J Bolado; C M van Meter; E S Ong; R M Evans
Journal:  Genes Dev       Date:  1998-10-15       Impact factor: 11.361

Review 7.  Polymorphisms of xenobiotic-metabolizing enzymes and susceptibility to cancer.

Authors:  A Hirvonen
Journal:  Environ Health Perspect       Date:  1999-02       Impact factor: 9.031

8.  Induction by Phenobarbital of Phase I and II Xenobiotic-Metabolizing Enzymes in Bovine Liver: An Overall Catalytic and Immunochemical Characterization.

Authors:  Michela Cantiello; Monica Carletti; Mery Giantin; Giulia Gardini; Francesca Capolongo; Paolo Cascio; Marianna Pauletto; Flavia Girolami; Mauro Dacasto; Carlo Nebbia
Journal:  Int J Mol Sci       Date:  2022-03-24       Impact factor: 5.923

Review 9.  The role of individual susceptibility in cancer burden related to environmental exposure.

Authors:  H Bartsch; E Hietanen
Journal:  Environ Health Perspect       Date:  1996-05       Impact factor: 9.031

Review 10.  Cytochrome p450 metabolism of betel quid-derived compounds: implications for the development of prevention strategies for oral and pharyngeal cancers.

Authors:  Che-Yi Lin; Tien-Szu Pan; Chun-Chan Ting; Shih-Shin Liang; Shu-Hung Huang; Hsiu-Yueh Liu; Edward Cheng-Chuan Ko; Chung-Wei Wu; Jen-Yang Tang; Ping-Ho Chen
Journal:  ScientificWorldJournal       Date:  2013-08-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.